Nalu Medical, Inc.: Business Overview, Financials & Competitive Analysis
Nalu Medical, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Nalu Medical represents breakthrough miniaturization in neurostimulation with validated commercial traction, now positioned for accelerated market expansion under Boston Scientific's ownership. Nalu demonstrates strong commercial momentum with FDA clearance for dual indications (SCS/PNS), strategic backing from Boston Scientific since 2017, and a pending acquisition at substantial valuation. The company.
What is Nalu Medical, Inc.'s industry? Nalu Medical, Inc. (nalumed.com) operates in Neurostimulation Devices. AskCyborg classifies Nalu Medical, Inc. under Neurostimulation Devices in its company registry.
Nalu Medical is a privately held medical device company based in Carlsbad, California that has developed the Nalu neurostimulation system, a battery-free, micro-implantable pulse generator currently FDA-cleared for bo...
Cyborg Score thesis
Nalu Medical represents breakthrough miniaturization in neurostimulation with validated commercial traction, now positioned for...
Read the full analyst-debate transcript →Get the Latest Nalu Medical, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNalu Medical, Inc. Overview
Pro stress-test →Nalu Medical is a privately held medical device company based in Carlsbad, California that has developed the Nalu neurostimulation system, a battery-free, micro-implantable pulse generator currently FDA-cleared for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The micro-implant delivers treatment capabilities similar to larger systems while offering advanced waveforms, extensive programming options, exceptional upgradability, and an expected service life of 18 years.
Strategic Profile
Pro stress-test →Boston Scientific entered into a definitive agreement to acquire Nalu Medical in October 2025 for approximately $533 million upfront for remaining equity not owned by Boston Scientific, which has been a strategic investor since 2017. The company addresses a significant unmet need in chronic neuropathic pain management with a miniaturized, wirelessly-powered implant that differentiates it from larger legacy neurostimulation devices.
Competitive Landscape
Pro stress-test →Nalu competes in the neurostimulation market against established players like Medtronic, Abbott, and Boston Scientific's existing portfolio, as well as emerging neuromodulation companies. The company's key differentiation is miniaturization and wireless power architecture, enabling better patient acceptance and implant longevity compared to larger, battery-dependent traditional systems.
Industry Context
Nalu Medical, Inc. operates in Neurostimulation Devices.
Key facts
Headquarters: Carlsbad, California, US · Employees: 252 (April 2026) · Revenue: $4M (2025)